Thienopyridine: Difference between revisions
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
m Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +) |
||
Line 12: | Line 12: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
Latest revision as of 15:31, 6 September 2012
WikiDoc Resources for Thienopyridine |
Articles |
---|
Most recent articles on Thienopyridine Most cited articles on Thienopyridine |
Media |
Powerpoint slides on Thienopyridine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Thienopyridine at Clinical Trials.gov Trial results on Thienopyridine Clinical Trials on Thienopyridine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Thienopyridine NICE Guidance on Thienopyridine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Thienopyridine Discussion groups on Thienopyridine Patient Handouts on Thienopyridine Directions to Hospitals Treating Thienopyridine Risk calculators and risk factors for Thienopyridine
|
Healthcare Provider Resources |
Causes & Risk Factors for Thienopyridine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Thienopyridines are a class of ADP receptor/P2Y12 inhibitors used for their anti-platelet activity.
Examples
These drugs include:
Prasugrel,[1] Ticlopidine (Ticlid), Clopidogrel (Plavix).
References
- ↑ Angiolillo DJ, Bates ER, Bass TA (2008). "Clinical profile of prasugrel, a novel thienopyridine". Am. Heart J. 156 (2 Suppl): S16–22. doi:10.1016/j.ahj.2008.06.005. PMID 18657682. Unknown parameter
|month=
ignored (help)